Carregant...
Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead
• Despite the burden of gene therapy trials for DMD patients there is great enthusiasm. • Collaborating with relevant bodies (pharmacy) at an early stage can accelerate progress. • A hub and spoke model may be an option for delivering clinical trials and follow up care.
Guardat en:
| Publicat a: | Neuromuscul Disord |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pergamon Press
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564510/ https://ncbi.nlm.nih.gov/pubmed/33158687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nmd.2020.10.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|